Clinical Trials Browser

Completed × Bone Diseases, Metabolic × Breast × Clear all

Bone Diseases, Metabolic, Breast Neoplasms

NCT00089661 2018-10-17

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer

Phase 3 Completed

252 enrolled 13 charts

Breast

Bone Diseases, Metabolic, Breast Neoplasms

NCT00485953 2017-10-13

REBBeCA II

Phase 4 Completed

109 enrolled 11 charts

Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT01277562 2015-06-08

Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer

Completed

56 enrolled

BreastGenitourinary

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Prostatic Neoplasms

NCT00859703 2013-10-31

RISAROS

Phase 3 Completed

20 enrolled

Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

Phase 4 Completed

12 enrolled 5 charts

Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

NCT00171340 2012-04-16

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Phase 3 Completed

1,065 enrolled 10 charts

Breast

Bone Diseases, Metabolic, Breast Neoplasms

NCT00082277 2011-01-26

SABRE

Phase 4 Completed

237 enrolled

Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Clinical Trials

REBECCA-OST

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer

REBBeCA II

Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer

RISAROS

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

SABRE